Guanfacine ER for the treatment of adolescent attention-deficit/hyperactivity disorder

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.15, 2012-10, pp. : 2207-2213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Guanfacine extended-release for attention-deficit/hyperactivity disorder (ADHD)

By Sallee Floyd R Eaton Katherine

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 15, 2010-10 ,pp. : 2549-2556

Informa Healthcare

Access to resources Recommend Favorite

Guanfacine Extended-Release: In Attention Deficit Hyperactivity Disorder

By Muir Victoria J. Perry Caroline M.

Drugs, Vol. 70, Iss. 13, 2010-09 ,pp. : 1693-1702

Adis International

Access to resources Recommend Favorite

New drugs for treatment of attention-deficit/hyperactivity disorder

By Chung Bowen Suzuki Alejandra R McGough James J

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 269-276

Informa Healthcare

Access to resources Recommend Favorite

New drugs for the treatment of attention-deficit/hyperactivity disorder

By Pataki Caroly S Feinberg David T McGough James J

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 2, 2004-11 ,pp. : 293-302

Informa Healthcare

Access to resources Recommend Favorite

Modafinil: A Treatment Alternative for Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Child and Adolescent Psychopharmacology News, Vol. 7, Iss. 6, 2002-12 ,pp. : 5-7

Guilford Publications Inc

Access to resources Recommend Favorite